Tag: Crohn’s Disease
Infliximab Introduction Has Not Cut IBD-Related Hospitalizations
Introduction of infliximab did not lead to drop in hospitalization, intestinal resection, colectomy
Biomarker Test Predicts Mild, Serious IBD in Newly Diagnosed
Test based on genetic signature of CD8 T cells during active disease
In Men, Low BMI Tied to Later Inflammatory Bowel Disease
Risk lasts through 40 years of adulthood for underweight adolescent men
Older Patients With Crohn Disease May Benefit From Early Combo Tx
Early step-up combo therapy includes tumor necrosis factor-α antagonist plus an antimetabolite
Malnutrition Ups Risk of Postop Issues in Pediatric Crohn Disease
In propensity-matched analysis, mild, severe malnutrition linked to elevated odds of complications
Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
CT-P13 is equivalent to reference product in primary outcome; no difference in safety outcomes
Psoriasis Linked to Increased Risk for Inflammatory Bowel Disease
Significant associations observed between psoriasis and risk for Crohn's disease, ulcerative colitis
Loss to Follow-Up Common With IBD, But Many Have Flare-Ups
Predictors of follow-up loss are long travel time and low C-reactive protein levels at diagnosis
Higher Levels of Fungus ID’d in Patients With Crohn’s
Patients with Crohn's had higher levels of Candida tropicalis, Escherichia coli, Serratia marcenscens
Azathioprine Appears to Improve Disease Course in Early Crohn’s
Prior bowel resection, smoking, and low hemoglobin tied to Crohn's-related surgery